CIK 0001658551
- Non-accelerated filer
- Smaller reporting company
Amylyx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464600503
- Phone
- +1 617-682-0917
- Business address
- 55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
- 4 Grant or award Chief Legal Officer acquired 80,560 shares (grant or award)
- 4 Grant or award Co-Chief Executive Officer acquired 179,850 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 96,910 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Co-Chief Executive Officer sold 4,135 shares at $18.73 ($77,440)
- 4 Open-market sale Co-Chief Executive Officer sold 4,135 shares at $18.73 ($77,440)
- 4 Open-market sale Chief Financial Officer sold 1,792 shares at $18.73 ($33,560)
- 4 Open-market sale Chief Legal Officer sold 1,540 shares at $18.73 ($28,841)
- 4 Grant or award Chief Financial Officer acquired 40,000 shares (grant or award)
- 4 Grant or award Co-Chief Executive Officer acquired 126,667 shares (grant or award)
- 4 Grant or award Co-Chief Executive Officer acquired 126,667 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 36,667 shares (grant or award)
- 4 Open-market sale Chief Legal Officer sold 2,838 shares at $18.76 ($53,231)
- 4 Gift Director gave 9,100 shares (gift)
- 4 Gift Director gave 94,350 shares (gift)
- 4 Open-market sale Co-Chief Executive Officer sold 5,841 shares at $16.33 ($95,372)
- 4 Open-market sale Chief Financial Officer sold 2,716 shares at $16.33 ($44,347)
- 4 Open-market sale Co-Chief Executive Officer sold 5,841 shares at $16.33 ($95,372)
- 4 Open-market sale Chief Medical Officer sold 2,812 shares at $16.33 ($45,915)
Page 6 of 11 · 207 filings